MK0686 in Postsurgery Dental Pain (0686-002)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00533403
First received: September 19, 2007
Last updated: May 8, 2014
Last verified: May 2014

September 19, 2007
May 8, 2014
June 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00533403 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
MK0686 in Postsurgery Dental Pain (0686-002)
Not Provided

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Not Provided
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Pain, Postoperative
Drug: MK0686
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
June 2004
Not Provided

Inclusion Criteria:

  • Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
  • Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria:

  • Patient has history of heart disease, asthma, pulmonary disease
  • Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery
Both
18 Years to 45 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00533403
0686-002, 2007_617
Not Provided
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp.
Not Provided
Study Director: Medical Monitor Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp.
May 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP